1 results ยท Page 1 of 1

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
Safety and Efficacy Study of RXIM002 in Severe, Relapsed or Refractory Autoimmune DiseasesDisease Attributes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Recurrence, autoimmune disease, immune system disorderRecruitingEarly phase 12026-01-23NCT07322718